Babatunde Odebunmi Orogbemi

Babatunde Orogbemi practices at Adventist HealthCare White Oak Medical Center in Silver Spring, Maryland, part of Columbia Union Conference.

Babatunde Orogbemi's NPI, 1568652717, was assigned on July 25, 2007. Babatunde Orogbemi holds Maryland license D68989.

Babatunde Orogbemi's primary practice is Adventist HealthCare White Oak Medical Center, at 11890 Healing Way, Silver Spring, MD 20904 in Montgomery County. The practice phone is (240) 637-4000.

Babatunde Orogbemi's primary practice is Adventist HealthCare White Oak Medical Center in Silver Spring, Maryland, part of Columbia Union Conference. Babatunde Orogbemi is also affiliated with Sentara Northern Virginia Medical Center. The medical group on file is MedStar Washington Hospital Center. Dmand AI also links Babatunde Orogbemi to 2 more hospitals and 4 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Babatunde Orogbemi practices, 4 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Babatunde Orogbemi's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Babatunde Orogbemi is licensed in Maryland.

CMS data shows 660 Medicare services from Babatunde Orogbemi across 4 procedure codes in 2024, for 627 Medicare patients. Medicare paid $99,659 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 627 Medicare patients who saw Babatunde Orogbemi in 2024. The largest group is 75 to 84, with 220 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 31% are also on Medicaid. Their average risk score is 2.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Babatunde Orogbemi's median patient age at 49, with 56% women.

In 2024, Babatunde Orogbemi wrote 132 Medicare Part D claims for 101 patients. 95% of them were for generic drugs. CMS names the drug for 53 of them, across 4 drugs with 11 or more claims each, at $212 in total drug cost. In 2023, CMS named 29 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Babatunde Orogbemi for performance year 2024, reported as part of a group. Babatunde Orogbemi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Babatunde Orogbemi from 1 drug or device company in 2021. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $95.